

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64172971 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.64172971 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.49941327 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.49941327 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11365746 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.02010262 |
| 7 | cysteine metabolic process (GO:0006534) | 5.54938299 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.52556226 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.52556226 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.52556226 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.51565060 |
| 12 | urea metabolic process (GO:0019627) | 5.39243678 |
| 13 | urea cycle (GO:0000050) | 5.39243678 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.36490727 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.34707292 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25234196 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.23488020 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.19627805 |
| 19 | homocysteine metabolic process (GO:0050667) | 5.18214831 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.13873652 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.95629749 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.94524280 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.92045036 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.78415976 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.77308971 |
| 26 | lysine catabolic process (GO:0006554) | 4.76737616 |
| 27 | lysine metabolic process (GO:0006553) | 4.76737616 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73926608 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.70633487 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69492585 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 4.67933433 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.64851488 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.60416545 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.59930520 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.59930520 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59930520 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.59177336 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58946016 |
| 39 | negative regulation of cell killing (GO:0031342) | 4.58946016 |
| 40 | phospholipid efflux (GO:0033700) | 4.56323580 |
| 41 | bile acid metabolic process (GO:0008206) | 4.55148085 |
| 42 | regulation of fibrinolysis (GO:0051917) | 4.54547768 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.53456092 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49659072 |
| 45 | glycine metabolic process (GO:0006544) | 4.44950153 |
| 46 | drug catabolic process (GO:0042737) | 4.42920379 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.41978394 |
| 48 | cellular glucuronidation (GO:0052695) | 4.41350694 |
| 49 | protein carboxylation (GO:0018214) | 4.39862547 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.39862547 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.39658442 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.39658442 |
| 53 | mannose metabolic process (GO:0006013) | 4.39515999 |
| 54 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38759319 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 4.36090648 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 4.35927950 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 4.34175476 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.29483072 |
| 59 | regulation of complement activation (GO:0030449) | 4.28612006 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.27944510 |
| 61 | triglyceride homeostasis (GO:0070328) | 4.27944510 |
| 62 | ethanol oxidation (GO:0006069) | 4.26296464 |
| 63 | detection of bacterium (GO:0016045) | 4.21131581 |
| 64 | detection of other organism (GO:0098543) | 4.18381858 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16125975 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.10408258 |
| 67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10011116 |
| 68 | response to peptidoglycan (GO:0032494) | 4.09367947 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07557569 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07557569 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07557569 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 4.07557569 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07557569 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 4.07557569 |
| 75 | cholesterol efflux (GO:0033344) | 4.06797425 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 4.04708984 |
| 77 | aldehyde catabolic process (GO:0046185) | 4.02927162 |
| 78 | glucuronate metabolic process (GO:0019585) | 4.02872875 |
| 79 | uronic acid metabolic process (GO:0006063) | 4.02872875 |
| 80 | bile acid and bile salt transport (GO:0015721) | 4.02612543 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 4.02336496 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 4.01668534 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.00192678 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.97798516 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.94111404 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.94111404 |
| 87 | tyrosine metabolic process (GO:0006570) | 3.93805559 |
| 88 | flavonoid metabolic process (GO:0009812) | 3.93061318 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.90568889 |
| 90 | short-chain fatty acid metabolic process (GO:0046459) | 3.88362371 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.85196775 |
| 92 | glutamate metabolic process (GO:0006536) | 3.84950803 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 3.82124457 |
| 94 | exogenous drug catabolic process (GO:0042738) | 3.80344644 |
| 95 | amine catabolic process (GO:0009310) | 3.79776991 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.79776991 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78607018 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.77227778 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 3.77054114 |
| 100 | coenzyme catabolic process (GO:0009109) | 3.76762016 |
| 101 | arginine metabolic process (GO:0006525) | 3.75124778 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 3.72068160 |
| 103 | benzene-containing compound metabolic process (GO:0042537) | 3.70260950 |
| 104 | sterol homeostasis (GO:0055092) | 3.69430808 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69349979 |
| 106 | drug transmembrane transport (GO:0006855) | 3.69234887 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68762188 |
| 108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63810826 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 3.63565409 |
| 110 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62761719 |
| 111 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.61304903 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.61248959 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.59062783 |
| 114 | heme transport (GO:0015886) | 3.58687792 |
| 115 | protein-lipid complex assembly (GO:0065005) | 3.58231681 |
| 116 | aspartate family amino acid catabolic process (GO:0009068) | 3.58087155 |
| 117 | organic acid catabolic process (GO:0016054) | 3.57848969 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 3.57848969 |
| 119 | immunoglobulin mediated immune response (GO:0016064) | 3.57322280 |
| 120 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54708033 |
| 121 | lipoprotein metabolic process (GO:0042157) | 3.54114250 |
| 122 | * nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53192590 |
| 123 | * pyridine nucleotide biosynthetic process (GO:0019363) | 3.53192590 |
| 124 | * NAD biosynthetic process (GO:0009435) | 3.51436255 |
| 125 | ketone body metabolic process (GO:1902224) | 3.50800741 |
| 126 | cellular extravasation (GO:0045123) | 3.50786146 |
| 127 | positive regulation of B cell differentiation (GO:0045579) | 3.47550503 |
| 128 | urate metabolic process (GO:0046415) | 3.47448339 |
| 129 | drug transport (GO:0015893) | 3.47038691 |
| 130 | positive thymic T cell selection (GO:0045059) | 3.44355919 |
| 131 | response to muramyl dipeptide (GO:0032495) | 3.44038415 |
| 132 | detection of external biotic stimulus (GO:0098581) | 3.43124666 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38633067 |
| 134 | response to type I interferon (GO:0034340) | 3.25344665 |
| 135 | leukocyte aggregation (GO:0070486) | 3.22033807 |
| 136 | regulation of mast cell degranulation (GO:0043304) | 3.21592898 |
| 137 | cellular response to type I interferon (GO:0071357) | 3.19830076 |
| 138 | type I interferon signaling pathway (GO:0060337) | 3.19830076 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 3.18872427 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.17657622 |
| 141 | germinal center formation (GO:0002467) | 3.15948244 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12628756 |
| 143 | thymic T cell selection (GO:0045061) | 3.11485626 |
| 144 | negative thymic T cell selection (GO:0045060) | 3.11103967 |
| 145 | regulation of B cell differentiation (GO:0045577) | 3.08827978 |
| 146 | T cell selection (GO:0045058) | 3.08122937 |
| 147 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07748985 |
| 148 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01997577 |
| 149 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00375635 |
| 150 | neutrophil activation (GO:0042119) | 3.00041128 |
| 151 | regulation of leukocyte degranulation (GO:0043300) | 2.99839658 |
| 152 | negative T cell selection (GO:0043383) | 2.98523232 |
| 153 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97673157 |
| 154 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97480412 |
| 155 | positive regulation of interferon-alpha production (GO:0032727) | 2.96616412 |
| 156 | detection of biotic stimulus (GO:0009595) | 2.94753975 |
| 157 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92327187 |
| 158 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89052880 |
| 159 | detection of molecule of bacterial origin (GO:0032490) | 2.88733505 |
| 160 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85660046 |
| 161 | response to interleukin-15 (GO:0070672) | 2.83892533 |
| 162 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83744397 |
| 163 | response to host immune response (GO:0052572) | 2.83744397 |
| 164 | NIK/NF-kappaB signaling (GO:0038061) | 2.83399364 |
| 165 | positive regulation of granulocyte differentiation (GO:0030854) | 2.81758652 |
| 166 | myeloid cell activation involved in immune response (GO:0002275) | 2.79557672 |
| 167 | phospholipid scrambling (GO:0017121) | 2.78463925 |
| 168 | regulation of interferon-alpha production (GO:0032647) | 2.76052932 |
| 169 | granulocyte activation (GO:0036230) | 2.75513272 |
| 170 | positive T cell selection (GO:0043368) | 2.74335039 |
| 171 | regulation of antigen processing and presentation (GO:0002577) | 2.74113250 |
| 172 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73109314 |
| 173 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72800579 |
| 174 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72157205 |
| 175 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69937203 |
| 176 | response to host (GO:0075136) | 2.69937203 |
| 177 | response to host defenses (GO:0052200) | 2.69937203 |
| 178 | negative regulation of interleukin-6 production (GO:0032715) | 2.69235728 |
| 179 | respiratory burst (GO:0045730) | 2.68637250 |
| 180 | defense response to protozoan (GO:0042832) | 2.66139191 |
| 181 | regulation of necroptotic process (GO:0060544) | 2.64924856 |
| 182 | B cell mediated immunity (GO:0019724) | 2.62822585 |
| 183 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.61593252 |
| 184 | response to protozoan (GO:0001562) | 2.59499098 |
| 185 | regulation of mast cell activation (GO:0033003) | 2.58708141 |
| 186 | macrophage activation (GO:0042116) | 2.57908523 |
| 187 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.56522252 |
| 188 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56212383 |
| 189 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56131571 |
| 190 | negative regulation of innate immune response (GO:0045824) | 2.55874637 |
| 191 | T cell migration (GO:0072678) | 2.54843048 |
| 192 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.53958705 |
| 193 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50936784 |
| 194 | interferon-gamma secretion (GO:0072643) | 2.50926229 |
| 195 | microglial cell activation (GO:0001774) | 2.46861263 |
| 196 | regulation of granulocyte differentiation (GO:0030852) | 2.46237506 |
| 197 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45804333 |
| 198 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.43443450 |
| 199 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42116784 |
| 200 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41732807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.30597021 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.51220998 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.32382882 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.61601027 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.82633418 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.61951711 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.56385765 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06261706 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.24832508 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24116325 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81006244 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.79169346 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.60326031 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.54694550 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.50275002 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43904492 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.32782997 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17599029 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16637720 |
| 20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.14839382 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07080334 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4967864 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98050049 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93591760 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92069209 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90747507 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90148525 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.89500699 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.86615018 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85168366 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.79991107 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76686021 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.75572727 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73210474 |
| 35 | * MAF_26560356_Chip-Seq_TH2_Human | 1.71551975 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70701228 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69180073 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63451805 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60450647 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59100323 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.57000613 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53884467 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42636076 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39159128 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38367135 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37849973 |
| 47 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36152154 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35295564 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34978827 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33991048 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30336646 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29304873 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27422405 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25801593 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.24899257 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24092674 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23658454 |
| 58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21783242 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21264461 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21069044 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19559656 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19378351 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19163877 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18485033 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18435449 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17484641 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15698661 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15506269 |
| 69 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13987878 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13602192 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11303353 |
| 72 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10542757 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08863626 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08600707 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07851262 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07527997 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06425068 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04800204 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03891425 |
| 80 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02885018 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02872916 |
| 82 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.02501226 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02035279 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01502006 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01456783 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98491570 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98038905 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97633363 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97029162 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95174874 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93478773 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90720718 |
| 93 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90259146 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90153868 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89691291 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89637360 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85476670 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84207292 |
| 99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80208224 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80077179 |
| 101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78455838 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76126686 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75948383 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75669792 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74364478 |
| 106 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.72717034 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71761392 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.71101823 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69694188 |
| 110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69368275 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68665614 |
| 112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68587650 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68096449 |
| 114 | * MYB_26560356_Chip-Seq_TH1_Human | 0.67754123 |
| 115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67490300 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67315149 |
| 117 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.67267289 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65881413 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.65661307 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.65629359 |
| 121 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65032242 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64878956 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63953343 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.63753882 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63728347 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62855411 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62099778 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61377941 |
| 129 | MAF_26560356_Chip-Seq_TH1_Human | 0.61328774 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60738266 |
| 131 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.60266823 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60096186 |
| 133 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.56708851 |
| 134 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56437863 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56255226 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.55537813 |
| 137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54724209 |
| 138 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.53774214 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.53533619 |
| 140 | UTX_26944678_Chip-Seq_JUKART_Human | 0.52235702 |
| 141 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.51553296 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.50113406 |
| 143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50056813 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49035591 |
| 145 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48836577 |
| 146 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.48360752 |
| 147 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.47913440 |
| 148 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.47730258 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.47620909 |
| 150 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.47580031 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.47526191 |
| 152 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.47318194 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46801793 |
| 154 | P300_27268052_Chip-Seq_Bcells_Human | 0.46592138 |
| 155 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.46328483 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.46278444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.48503647 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.31353270 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.74278041 |
| 4 | MP0005365_abnormal_bile_salt | 5.62968486 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.90072795 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05282554 |
| 7 | MP0003252_abnormal_bile_duct | 3.70130562 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.38287580 |
| 9 | MP0009840_abnormal_foam_cell | 3.29353141 |
| 10 | MP0003303_peritoneal_inflammation | 3.12852924 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.93655089 |
| 12 | MP0005332_abnormal_amino_acid | 2.83561108 |
| 13 | MP0005083_abnormal_biliary_tract | 2.66506480 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.62258631 |
| 15 | MP0005671_abnormal_response_to | 2.52502225 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.39795536 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.31049174 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.27376042 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.25894186 |
| 20 | MP0002723_abnormal_immune_serum | 2.24594137 |
| 21 | MP0009278_abnormal_bone_marrow | 2.16985878 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.15489777 |
| 23 | MP0001819_abnormal_immune_cell | 2.15290640 |
| 24 | MP0003195_calcinosis | 2.14042802 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.13536907 |
| 26 | MP0000609_abnormal_liver_physiology | 2.12064357 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.08858278 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.94356008 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.86674622 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.85346843 |
| 31 | MP0001764_abnormal_homeostasis | 1.83274567 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.82012897 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.82012897 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.81264892 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.77218164 |
| 36 | MP0002405_respiratory_system_inflammati | 1.72013514 |
| 37 | MP0000716_abnormal_immune_system | 1.69359322 |
| 38 | MP0002398_abnormal_bone_marrow | 1.68932815 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.66526054 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.64421953 |
| 41 | MP0008260_abnormal_autophagy | 1.61725306 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.60052599 |
| 43 | MP0005310_abnormal_salivary_gland | 1.59775907 |
| 44 | MP0003866_abnormal_defecation | 1.57811394 |
| 45 | MP0004381_abnormal_hair_follicle | 1.57120348 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53907738 |
| 47 | MP0003868_abnormal_feces_composition | 1.49991640 |
| 48 | MP0003011_delayed_dark_adaptation | 1.45786534 |
| 49 | MP0003186_abnormal_redox_activity | 1.43893966 |
| 50 | MP0002722_abnormal_immune_system | 1.43054919 |
| 51 | MP0009697_abnormal_copulation | 1.40569261 |
| 52 | MP0002429_abnormal_blood_cell | 1.39941089 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.37130534 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.29125748 |
| 55 | MP0003045_fibrosis | 1.26124903 |
| 56 | MP0009764_decreased_sensitivity_to | 1.25034072 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.23395243 |
| 58 | MP0000598_abnormal_liver_morphology | 1.22951888 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.19484315 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.17516479 |
| 61 | MP0000858_altered_metastatic_potential | 1.16335066 |
| 62 | MP0001851_eye_inflammation | 1.16239115 |
| 63 | MP0005451_abnormal_body_composition | 1.16187209 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.14553592 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.10502096 |
| 66 | MP0008469_abnormal_protein_level | 1.09586672 |
| 67 | MP0003828_pulmonary_edema | 1.08648512 |
| 68 | MP0009763_increased_sensitivity_to | 1.05577434 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.04876949 |
| 70 | MP0002933_joint_inflammation | 1.03706150 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.02591971 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.01140218 |
| 73 | MP0006054_spinal_hemorrhage | 1.00541772 |
| 74 | MP0000604_amyloidosis | 0.99914035 |
| 75 | MP0002132_abnormal_respiratory_system | 0.98853688 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.98689381 |
| 77 | MP0005647_abnormal_sex_gland | 0.95429741 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.93696245 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.92668268 |
| 80 | MP0004883_abnormal_blood_vessel | 0.91932304 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.91100524 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.88850705 |
| 83 | MP0003724_increased_susceptibility_to | 0.87930128 |
| 84 | MP0005670_abnormal_white_adipose | 0.84620156 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.84501186 |
| 86 | MP0005408_hypopigmentation | 0.81349458 |
| 87 | MP0004147_increased_porphyrin_level | 0.80672795 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.80417517 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.79695666 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.78011479 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.77018033 |
| 92 | MP0003075_altered_response_to | 0.76700732 |
| 93 | MP0001849_ear_inflammation | 0.75399606 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.75280509 |
| 95 | MP0008004_abnormal_stomach_pH | 0.74646683 |
| 96 | MP0000490_abnormal_crypts_of | 0.74253418 |
| 97 | MP0005164_abnormal_response_to | 0.73698781 |
| 98 | MP0005390_skeleton_phenotype | 0.72367250 |
| 99 | MP0001853_heart_inflammation | 0.71187767 |
| 100 | MP0004510_myositis | 0.69857819 |
| 101 | MP0003091_abnormal_cell_migration | 0.69765883 |
| 102 | MP0005266_abnormal_metabolism | 0.69586728 |
| 103 | MP0002796_impaired_skin_barrier | 0.68875016 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.67446011 |
| 105 | MP0004130_abnormal_muscle_cell | 0.67411702 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.67175766 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.66385572 |
| 108 | MP0002971_abnormal_brown_adipose | 0.66139373 |
| 109 | MP0003795_abnormal_bone_structure | 0.65866021 |
| 110 | MP0000371_diluted_coat_color | 0.65670909 |
| 111 | MP0001756_abnormal_urination | 0.65666802 |
| 112 | MP0003436_decreased_susceptibility_to | 0.65234613 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.64793813 |
| 114 | MP0002006_tumorigenesis | 0.64178450 |
| 115 | MP0005377_hearing/vestibular/ear_phenot | 0.63875425 |
| 116 | MP0003878_abnormal_ear_physiology | 0.63875425 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.63736543 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.63490311 |
| 119 | MP0000685_abnormal_immune_system | 0.63040274 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.61690793 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.61485731 |
| 122 | MP0001873_stomach_inflammation | 0.61364408 |
| 123 | MP0002254_reproductive_system_inflammat | 0.60729020 |
| 124 | MP0005025_abnormal_response_to | 0.58318446 |
| 125 | MP0009785_altered_susceptibility_to | 0.56018020 |
| 126 | MP0005334_abnormal_fat_pad | 0.55123447 |
| 127 | MP0001800_abnormal_humoral_immune | 0.53370952 |
| 128 | MP0008873_increased_physiological_sensi | 0.51645335 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.50415258 |
| 130 | MP0006082_CNS_inflammation | 0.50342945 |
| 131 | MP0002419_abnormal_innate_immunity | 0.48828966 |
| 132 | MP0001663_abnormal_digestive_system | 0.48231841 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.48157028 |
| 134 | MP0005058_abnormal_lysosome_morphology | 0.47694819 |
| 135 | MP0005448_abnormal_energy_balance | 0.47514910 |
| 136 | MP0002928_abnormal_bile_duct | 0.46299598 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.45797868 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.44180343 |
| 139 | MP0004043_abnormal_pH_regulation | 0.43215328 |
| 140 | MP0005535_abnormal_body_temperature | 0.42500945 |
| 141 | MP0003718_maternal_effect | 0.42215579 |
| 142 | MP0004947_skin_inflammation | 0.42131947 |
| 143 | MP0008872_abnormal_physiological_respon | 0.41558121 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.40714886 |
| 145 | MP0000249_abnormal_blood_vessel | 0.40560177 |
| 146 | MP0003690_abnormal_glial_cell | 0.39694931 |
| 147 | MP0009115_abnormal_fat_cell | 0.39406682 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.38094679 |
| 149 | MP0005166_decreased_susceptibility_to | 0.37826174 |
| 150 | MP0005075_abnormal_melanosome_morpholog | 0.37776240 |
| 151 | MP0005023_abnormal_wound_healing | 0.36890896 |
| 152 | MP0001790_abnormal_immune_system | 0.36829305 |
| 153 | MP0005387_immune_system_phenotype | 0.36829305 |
| 154 | MP0000689_abnormal_spleen_morphology | 0.35836272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.40199012 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.31997535 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.94450117 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.90523971 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.80810815 |
| 6 | Xanthomatosis (HP:0000991) | 5.59818532 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.35226883 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.10686387 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.59586932 |
| 10 | Hyperammonemia (HP:0001987) | 4.48440176 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.48315522 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.48107314 |
| 13 | Hyperglycinemia (HP:0002154) | 4.44775929 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.41867481 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.38880419 |
| 16 | Complement deficiency (HP:0004431) | 4.28939043 |
| 17 | Hyperglycinuria (HP:0003108) | 4.23780564 |
| 18 | Abnormality of macrophages (HP:0004311) | 4.17993844 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16939035 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.12318897 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.12318897 |
| 22 | Joint hemorrhage (HP:0005261) | 4.04457158 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.03562870 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.95763883 |
| 25 | Ketosis (HP:0001946) | 3.94214081 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.92640709 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.87205433 |
| 28 | Fat malabsorption (HP:0002630) | 3.86381686 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.80628217 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80421542 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79639440 |
| 32 | Myositis (HP:0100614) | 3.73698836 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.73407919 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66902718 |
| 35 | Epidermoid cyst (HP:0200040) | 3.66140067 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.64604112 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.58208987 |
| 38 | Colitis (HP:0002583) | 3.53729043 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.52900797 |
| 40 | Increased IgE level (HP:0003212) | 3.48860112 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42405254 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.41853730 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.36998688 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36767286 |
| 45 | Inflammation of the large intestine (HP:0002037) | 3.32748473 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 3.31931658 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.30454776 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.28764089 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28056080 |
| 50 | Dysostosis multiplex (HP:0000943) | 3.27293808 |
| 51 | Obstructive lung disease (HP:0006536) | 3.23659521 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23659521 |
| 53 | Orchitis (HP:0100796) | 3.21660980 |
| 54 | Meningitis (HP:0001287) | 3.21585244 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 3.19239682 |
| 56 | Prolonged bleeding time (HP:0003010) | 3.15939650 |
| 57 | Pustule (HP:0200039) | 3.13344827 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 3.11568906 |
| 59 | Abnormality of complement system (HP:0005339) | 3.11216914 |
| 60 | Recurrent skin infections (HP:0001581) | 3.10715972 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10655454 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09944050 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07731833 |
| 64 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07731833 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.03994536 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 3.03994536 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 3.01873349 |
| 68 | Generalized aminoaciduria (HP:0002909) | 3.01000790 |
| 69 | Gingivitis (HP:0000230) | 2.95736723 |
| 70 | Vasculitis (HP:0002633) | 2.92259959 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.92028851 |
| 72 | Recurrent viral infections (HP:0004429) | 2.90828026 |
| 73 | Metabolic acidosis (HP:0001942) | 2.86580045 |
| 74 | Stomatitis (HP:0010280) | 2.86304911 |
| 75 | Cellulitis (HP:0100658) | 2.83466583 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.83191818 |
| 77 | Optic neuritis (HP:0100653) | 2.80076854 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.80076854 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.79791451 |
| 80 | Epistaxis (HP:0000421) | 2.78519159 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.77029363 |
| 82 | Acanthocytosis (HP:0001927) | 2.76934880 |
| 83 | Steatorrhea (HP:0002570) | 2.76724284 |
| 84 | Ketoacidosis (HP:0001993) | 2.76407309 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.74122591 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.74022495 |
| 87 | Myocardial infarction (HP:0001658) | 2.69046917 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68928598 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.68928598 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68049981 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68049981 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68049981 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.61840898 |
| 94 | Lethargy (HP:0001254) | 2.60581460 |
| 95 | Malnutrition (HP:0004395) | 2.56245338 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 2.54681666 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.48384875 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 2.48384875 |
| 99 | Hypochromic anemia (HP:0001931) | 2.48197452 |
| 100 | Proximal tubulopathy (HP:0000114) | 2.46913578 |
| 101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46247062 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46247062 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46247062 |
| 104 | Spontaneous abortion (HP:0005268) | 2.45234901 |
| 105 | Encephalitis (HP:0002383) | 2.44956079 |
| 106 | Chest pain (HP:0100749) | 2.44652291 |
| 107 | Abnormality of the fingertips (HP:0001211) | 2.44546918 |
| 108 | Vascular calcification (HP:0004934) | 2.44406867 |
| 109 | Chronic diarrhea (HP:0002028) | 2.42646324 |
| 110 | Gout (HP:0001997) | 2.42512496 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 2.40054236 |
| 112 | Osteomyelitis (HP:0002754) | 2.37346235 |
| 113 | Loss of speech (HP:0002371) | 2.36654370 |
| 114 | Petechiae (HP:0000967) | 2.35989155 |
| 115 | Increased serum ferritin (HP:0003281) | 2.35489831 |
| 116 | Urticaria (HP:0001025) | 2.35151443 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.34668168 |
| 118 | Pulmonary infiltrates (HP:0002113) | 2.33799700 |
| 119 | Hemoptysis (HP:0002105) | 2.33535257 |
| 120 | Abnormality of T cells (HP:0002843) | 2.33372709 |
| 121 | Esophageal varix (HP:0002040) | 2.32566554 |
| 122 | Spastic diplegia (HP:0001264) | 2.27674351 |
| 123 | Gingival bleeding (HP:0000225) | 2.26842680 |
| 124 | Irritability (HP:0000737) | 2.25678286 |
| 125 | Skin nodule (HP:0200036) | 2.25485275 |
| 126 | Granulocytopenia (HP:0001913) | 2.23052739 |
| 127 | Renal cortical cysts (HP:0000803) | 2.18615142 |
| 128 | Hypochromic microcytic anemia (HP:0004840) | 2.17705969 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 2.16554972 |
| 130 | Hypoglycemic seizures (HP:0002173) | 2.16397440 |
| 131 | Cardiovascular calcification (HP:0011915) | 2.15855049 |
| 132 | Thrombophlebitis (HP:0004418) | 2.15788833 |
| 133 | Menorrhagia (HP:0000132) | 2.15221963 |
| 134 | Abnormality of urine glucose concentration (HP:0011016) | 2.15214496 |
| 135 | Glycosuria (HP:0003076) | 2.15214496 |
| 136 | Late onset (HP:0003584) | 2.14406094 |
| 137 | Pancreatitis (HP:0001733) | 2.13648169 |
| 138 | Cerebral edema (HP:0002181) | 2.13629964 |
| 139 | Arterial thrombosis (HP:0004420) | 2.13381988 |
| 140 | J-shaped sella turcica (HP:0002680) | 2.13002931 |
| 141 | Vomiting (HP:0002013) | 2.12411917 |
| 142 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11850598 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 2.11425502 |
| 144 | Glomerulonephritis (HP:0000099) | 2.11226864 |
| 145 | Opisthotonus (HP:0002179) | 2.10619537 |
| 146 | Poikilocytosis (HP:0004447) | 2.09155261 |
| 147 | Cholecystitis (HP:0001082) | 2.08851275 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 2.08851275 |
| 149 | Mitral stenosis (HP:0001718) | 2.08686096 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05815166 |
| 151 | Lymphopenia (HP:0001888) | 2.05679915 |
| 152 | Viral hepatitis (HP:0006562) | 2.04432826 |
| 153 | Nausea (HP:0002018) | 2.03255001 |
| 154 | Purpura (HP:0000979) | 2.02094946 |
| 155 | Abnormality of T cell number (HP:0011839) | 2.01702109 |
| 156 | Autoimmune hemolytic anemia (HP:0001890) | 2.01188548 |
| 157 | T lymphocytopenia (HP:0005403) | 2.00950710 |
| 158 | Abnormal gallbladder morphology (HP:0012437) | 2.00137527 |
| 159 | Polygenic inheritance (HP:0010982) | 1.98698084 |
| 160 | Emphysema (HP:0002097) | 1.98604246 |
| 161 | Hypergammaglobulinemia (HP:0010702) | 1.98440854 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.98176727 |
| 163 | Elevated hepatic transaminases (HP:0002910) | 1.97707006 |
| 164 | Cholelithiasis (HP:0001081) | 1.96910427 |
| 165 | Neonatal onset (HP:0003623) | 1.96537501 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95966841 |
| 167 | Restrictive lung disease (HP:0002091) | 1.95636829 |
| 168 | Amyloidosis (HP:0011034) | 1.95041831 |
| 169 | Pulmonary embolism (HP:0002204) | 1.94135807 |
| 170 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93801207 |
| 171 | Hypertensive crisis (HP:0100735) | 1.92457967 |
| 172 | Peritonitis (HP:0002586) | 1.91609480 |
| 173 | IgM deficiency (HP:0002850) | 1.91574600 |
| 174 | Papilloma (HP:0012740) | 1.91432168 |
| 175 | Verrucae (HP:0200043) | 1.91432168 |
| 176 | Hemorrhage of the eye (HP:0011885) | 1.90512208 |
| 177 | Leukocytosis (HP:0001974) | 1.90401974 |
| 178 | Hepatic necrosis (HP:0002605) | 1.89357699 |
| 179 | Keratoconjunctivitis (HP:0001096) | 1.88915311 |
| 180 | Interstitial pulmonary disease (HP:0006530) | 1.87999184 |
| 181 | Increased purine levels (HP:0004368) | 1.86664661 |
| 182 | Hyperuricemia (HP:0002149) | 1.86664661 |
| 183 | Abnormality of the peritoneum (HP:0002585) | 1.86207391 |
| 184 | Flat acetabular roof (HP:0003180) | 1.85814934 |
| 185 | Thin bony cortex (HP:0002753) | 1.83537832 |
| 186 | Increased mean platelet volume (HP:0011877) | 1.83522801 |
| 187 | Abnormal cartilage morphology (HP:0002763) | 1.83398458 |
| 188 | Skin ulcer (HP:0200042) | 1.82759634 |
| 189 | Megaloblastic anemia (HP:0001889) | 1.82749089 |
| 190 | Thrombocytosis (HP:0001894) | 1.82714040 |
| 191 | Alkalosis (HP:0001948) | 1.82143539 |
| 192 | Nephritis (HP:0000123) | 1.77242421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.54363491 |
| 2 | ERN1 | 3.77902598 |
| 3 | FGFR4 | 3.54493147 |
| 4 | RIPK4 | 3.46677813 |
| 5 | TAOK3 | 2.72846026 |
| 6 | SIK1 | 2.70809142 |
| 7 | PRPF4B | 2.61034582 |
| 8 | MST1R | 2.48404764 |
| 9 | TNK2 | 2.43267444 |
| 10 | MAP4K1 | 2.35300883 |
| 11 | INSRR | 2.30582058 |
| 12 | PKN2 | 2.15023207 |
| 13 | TYK2 | 2.11442175 |
| 14 | EPHA3 | 2.07280715 |
| 15 | MAPK11 | 1.96221347 |
| 16 | FLT3 | 1.95020584 |
| 17 | GRK6 | 1.93674499 |
| 18 | MAP2K3 | 1.85627690 |
| 19 | SMG1 | 1.75279621 |
| 20 | LATS1 | 1.66314384 |
| 21 | MUSK | 1.66105867 |
| 22 | TGFBR2 | 1.64015433 |
| 23 | FES | 1.63844119 |
| 24 | TBK1 | 1.60941174 |
| 25 | MAP2K6 | 1.57936370 |
| 26 | ERBB4 | 1.51667527 |
| 27 | MAP3K14 | 1.51527703 |
| 28 | IRAK3 | 1.50789916 |
| 29 | PTK6 | 1.49381621 |
| 30 | NEK9 | 1.45250368 |
| 31 | STK38L | 1.41337341 |
| 32 | KDR | 1.41195929 |
| 33 | SCYL2 | 1.37272366 |
| 34 | MAP3K11 | 1.34772976 |
| 35 | CDC42BPA | 1.32440413 |
| 36 | IKBKE | 1.30400592 |
| 37 | MAP3K10 | 1.29606840 |
| 38 | KIT | 1.25616173 |
| 39 | FRK | 1.25192316 |
| 40 | SIK2 | 1.21386078 |
| 41 | HCK | 1.20201287 |
| 42 | TRIB3 | 1.18951158 |
| 43 | STK10 | 1.17995793 |
| 44 | PIK3CG | 1.17837979 |
| 45 | FGR | 1.05403151 |
| 46 | ICK | 1.04973812 |
| 47 | JAK1 | 1.04621304 |
| 48 | SIK3 | 1.03357546 |
| 49 | JAK3 | 1.01595445 |
| 50 | MAP3K3 | 1.01028315 |
| 51 | NUAK1 | 0.99150460 |
| 52 | ZAP70 | 0.98652531 |
| 53 | IRAK4 | 0.98441108 |
| 54 | MAP3K13 | 0.97574526 |
| 55 | PRKD2 | 0.97517764 |
| 56 | PDK1 | 0.97506787 |
| 57 | STK16 | 0.95214921 |
| 58 | PDPK1 | 0.94844781 |
| 59 | JAK2 | 0.94051771 |
| 60 | PRKAA2 | 0.93598956 |
| 61 | ERBB2 | 0.93497127 |
| 62 | MAP3K7 | 0.93019319 |
| 63 | HIPK2 | 0.91206132 |
| 64 | CDK4 | 0.90835893 |
| 65 | ACVR1B | 0.90500414 |
| 66 | FGFR3 | 0.89810863 |
| 67 | TGFBR1 | 0.88618260 |
| 68 | MARK3 | 0.88272421 |
| 69 | CDK6 | 0.88251265 |
| 70 | TAOK1 | 0.88102550 |
| 71 | MAP2K4 | 0.87807266 |
| 72 | MAPK15 | 0.87126183 |
| 73 | ITK | 0.84449312 |
| 74 | CSF1R | 0.79293121 |
| 75 | BTK | 0.79255203 |
| 76 | MARK2 | 0.78980965 |
| 77 | TLK1 | 0.77919918 |
| 78 | BLK | 0.71736995 |
| 79 | CHUK | 0.70765063 |
| 80 | RPS6KL1 | 0.70443593 |
| 81 | RPS6KC1 | 0.70443593 |
| 82 | LRRK2 | 0.70192098 |
| 83 | EPHB1 | 0.69369355 |
| 84 | CSK | 0.68407819 |
| 85 | PRKG2 | 0.65770771 |
| 86 | IRAK1 | 0.65757852 |
| 87 | RPS6KA2 | 0.63828753 |
| 88 | TEC | 0.63221966 |
| 89 | RPS6KA6 | 0.63184127 |
| 90 | MYLK | 0.63162718 |
| 91 | MAP3K6 | 0.61826786 |
| 92 | BMX | 0.60201621 |
| 93 | IKBKB | 0.59193973 |
| 94 | NME2 | 0.58975789 |
| 95 | CDK12 | 0.57903539 |
| 96 | ABL2 | 0.56569644 |
| 97 | MAPK4 | 0.55370532 |
| 98 | MAP3K8 | 0.55144865 |
| 99 | NLK | 0.53235353 |
| 100 | IRAK2 | 0.52674121 |
| 101 | TXK | 0.52109367 |
| 102 | RET | 0.49770063 |
| 103 | MAP2K2 | 0.48703990 |
| 104 | MAPK12 | 0.48589540 |
| 105 | MAPKAPK2 | 0.48486819 |
| 106 | MELK | 0.47966255 |
| 107 | BMPR2 | 0.47078041 |
| 108 | MAPK7 | 0.46862732 |
| 109 | MTOR | 0.46276549 |
| 110 | LYN | 0.45351993 |
| 111 | MST4 | 0.45142655 |
| 112 | NEK2 | 0.44899071 |
| 113 | LCK | 0.44506965 |
| 114 | SYK | 0.44127347 |
| 115 | PTK2B | 0.43928416 |
| 116 | TESK2 | 0.41823383 |
| 117 | PRKAA1 | 0.41571149 |
| 118 | MET | 0.41009198 |
| 119 | LMTK2 | 0.40993582 |
| 120 | TAOK2 | 0.40491626 |
| 121 | TTK | 0.39329116 |
| 122 | EPHA2 | 0.39158313 |
| 123 | TRPM7 | 0.38905048 |
| 124 | PIM1 | 0.37947285 |
| 125 | DYRK1B | 0.37473449 |
| 126 | YES1 | 0.37402171 |
| 127 | MAP3K1 | 0.37346967 |
| 128 | PIK3CA | 0.36861689 |
| 129 | MATK | 0.36461631 |
| 130 | MAPK3 | 0.35852280 |
| 131 | RIPK1 | 0.32495019 |
| 132 | GSK3A | 0.32468094 |
| 133 | IGF1R | 0.32130720 |
| 134 | PRKCQ | 0.30657024 |
| 135 | PRKACG | 0.30149979 |
| 136 | EEF2K | 0.29462982 |
| 137 | CDK9 | 0.28368056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.95119453 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32853243 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.82223411 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82012220 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72199316 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58204534 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57025730 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54077855 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51608607 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48906665 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46942612 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37863700 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35681251 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.35488074 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33713264 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33043810 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32401868 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.28842605 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15824480 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.03712231 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02960575 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02163492 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95120052 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.95017631 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92623762 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91597135 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.87396762 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82752956 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81643540 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80159014 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78907622 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76953929 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76610998 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76560267 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76547777 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76365867 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75873761 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73785514 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72613878 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.69273019 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69101795 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65664409 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64596110 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59070048 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58271266 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57797316 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55817402 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55064867 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.54354078 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50172442 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47494295 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45891979 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45232739 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45028676 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.43129502 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42775182 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41654621 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 1.41256101 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41012910 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39296317 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38850566 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.38531712 |
| 63 | Measles_Homo sapiens_hsa05162 | 1.37367814 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37082814 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35865729 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33989480 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31685298 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31144814 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30393431 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.29603811 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29303955 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29234811 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25792605 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24979010 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22142591 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20688451 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18688734 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18195019 |
| 79 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17142980 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17101427 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 1.14216576 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13468537 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12541063 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12320097 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10862270 |
| 86 | Malaria_Homo sapiens_hsa05144 | 1.10187327 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10011631 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07556093 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 1.06525021 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04991535 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00838323 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00395113 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00036473 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98816465 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95765508 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92282067 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.91113554 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91013241 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90971347 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89407039 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.89389947 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87487042 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86003238 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85721877 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85336719 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.85040078 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83717667 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81740345 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79372543 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79076187 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78210455 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76018935 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.74956242 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.74136297 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73226393 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72909830 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70875855 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69178486 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68339551 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64602097 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.61351985 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.60318172 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60257213 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58536878 |
| 125 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57748347 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56941100 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56215862 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56144718 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52565447 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52554768 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.52251044 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52120331 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51107334 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50244987 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.49683105 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48611599 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48438264 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47647537 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47177250 |
| 140 | Salmonella infection_Homo sapiens_hsa05132 | 0.46272620 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43839232 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41558198 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39658511 |
| 144 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38817458 |
| 145 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37214885 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35739666 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27534199 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23928822 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.19745633 |
| 150 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17123649 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15779123 |
| 152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15319959 |
| 153 | Mineral absorption_Homo sapiens_hsa04978 | 0.15220759 |
| 154 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09919029 |
| 155 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.09499546 |
| 156 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08964498 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07145043 |
| 158 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.06670616 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04728993 |
| 160 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01364449 |
| 161 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1352370 |
| 162 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1295156 |
| 163 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1282759 |
| 164 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1197672 |
| 165 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1019748 |
| 166 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0962329 |
| 167 | Prion diseases_Homo sapiens_hsa05020 | -0.0918156 |
| 168 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0881871 |
| 169 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0853899 |
| 170 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0767940 |
| 171 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0555284 |
| 172 | Hepatitis C_Homo sapiens_hsa05160 | -0.0503307 |
| 173 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0493643 |
| 174 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0480082 |
| 175 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0476245 |
| 176 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0424141 |

